AU5440799A - Method and drug for the treatment of coronary heart disease and for the prevention of restenosis after percutaneous transluminal coronary angioplasty - Google Patents
Method and drug for the treatment of coronary heart disease and for the prevention of restenosis after percutaneous transluminal coronary angioplastyInfo
- Publication number
- AU5440799A AU5440799A AU54407/99A AU5440799A AU5440799A AU 5440799 A AU5440799 A AU 5440799A AU 54407/99 A AU54407/99 A AU 54407/99A AU 5440799 A AU5440799 A AU 5440799A AU 5440799 A AU5440799 A AU 5440799A
- Authority
- AU
- Australia
- Prior art keywords
- restenosis
- drug
- prevention
- treatment
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
WO801444 | 1998-09-17 | ||
IB9801444 | 1998-09-17 | ||
PCT/IB1999/001545 WO2000016759A2 (en) | 1998-09-17 | 1999-09-14 | Genistein for the treatment of coronary heart disease and for the prevention of restenosis after percutaneous transluminal coronary angioplasty |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5440799A true AU5440799A (en) | 2000-04-10 |
Family
ID=11004753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54407/99A Abandoned AU5440799A (en) | 1998-09-17 | 1999-09-14 | Method and drug for the treatment of coronary heart disease and for the prevention of restenosis after percutaneous transluminal coronary angioplasty |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5440799A (en) |
WO (1) | WO2000016759A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008200518B2 (en) * | 2001-03-16 | 2010-04-01 | Novogen Research Pty Ltd | Treatment of restenosis |
WO2002074307A1 (en) * | 2001-03-16 | 2002-09-26 | Novogen Research Pty Ltd | Treatment of restenosis |
AU2006200292B2 (en) * | 2001-03-16 | 2007-11-22 | Novogen Research Pty Ltd | Treatment of restenosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ252051A (en) * | 1992-05-19 | 1996-10-28 | Graham Edmund Kelly | Health supplement comprising a phyto-oestrogen selected from genistein, daidzein, biochanin and/or formononetin |
US5516528A (en) * | 1995-01-13 | 1996-05-14 | Wake Forest University | Dietary phytoestrogen in estrogen replacement therapy |
JP3476604B2 (en) * | 1995-08-22 | 2003-12-10 | 鐘淵化学工業株式会社 | Method for manufacturing stent with drug attached / coated |
AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
GB9814620D0 (en) * | 1998-07-06 | 1998-09-02 | Karobio Ab | Vasculoprotector |
-
1999
- 1999-09-14 AU AU54407/99A patent/AU5440799A/en not_active Abandoned
- 1999-09-14 WO PCT/IB1999/001545 patent/WO2000016759A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000016759A2 (en) | 2000-03-30 |
WO2000016759A3 (en) | 2000-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7628500A (en) | Dilatation/centering catheter for the treatment of stenosis | |
AU3241099A (en) | Angioplasty and stent delivery catheter | |
AU7913800A (en) | Catheter for carrying out the combined examination of the left ventricle and of the right and left coronary arteries | |
AU8661998A (en) | Cryotherapy method for reducing tissue injury after balloon angioplasty or stentimplantation | |
GB2347685B (en) | NiTi-based medical guidewire and method of producing the same | |
EP0830178A4 (en) | Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis | |
EP1022945A4 (en) | Method and formulation for treating vascular disease | |
AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
AU7091900A (en) | Coating having biological activity and medical implant having surface carrying the same and method | |
AU1482601A (en) | Stent delivery catheter assembly and method of use | |
AU5056300A (en) | Devices and compounds for treating arterial restenosis | |
HK1026643A1 (en) | Angioplasty catheter | |
AU1025199A (en) | Coated medical implants, method for producing them, and use of the same for preventing restenosis | |
EP1191941A4 (en) | A method for the prophylaxis and/or treatment of medical disorders | |
DE69215954D1 (en) | Angioplasty catheter and its manufacturing process | |
AU5537994A (en) | Therapeutic treatment for inhibiting vascular restenosis | |
AU6914296A (en) | Left coronary artery catheter | |
AU4069095A (en) | Medicaments for the treatment of restenosis and arterial sclerosis | |
AU9016898A (en) | Methods and compositions for treatment of restenosis | |
WO1999022722A3 (en) | Use of macrolides for the treatment of cancer and macular degeneration | |
EP1018965A4 (en) | Method of treating the syndrome of coronary heart disease risk factors in humans | |
WO2003031447A3 (en) | Pyrimidine derivatives | |
AU3142400A (en) | A pharmaceutical composition for treating angiocardiopathy and the method of producing thereof | |
AU3728095A (en) | Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis | |
AU2476200A (en) | Ribozyme therapy for the treatment and/or prevention of restenosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |